Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis

S Seregard, G Lundell, H Svedberg, T Kivelä - Ophthalmology, 2004 - Elsevier
PURPOSE: To assess change in incidence of retinoblastoma in Northern Europe and to
compare commonly used methods for calculating its incidence against birth cohort analysis. …

Orbit deformities in craniofacial neurofibromatosis type 1

…, TM Bosley, H Svedberg - American Journal of …, 2003 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The possible relationship of orbit deformities in neurofibromatosis
type 1 (NF1) to plexiform neurofibromas (PNFs) have not been fully elucidated. Our …

Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1

…, TM Bosley, D Liu, H Svedberg… - American journal …, 2002 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Sphenoid dysplasia associated with neurofibromatosis
type 1 is classically thought to be primarily related to abnormal development of the sphenoid …

Application of the ICare rebound tonometer in healthy infants

A Lundvall, H Svedberg, E Chen - Journal of glaucoma, 2011 - journals.lww.com
Purpose To study the tolerability of the ICare rebound tonometer (RBT) and to establish
reference values of the intraocular pressure (IOP) in healthy infants. Participants and Methods …

Changes in corneal thickness and curvature after different excimer laser photorefractive procedures and their impact on intraocular pressure measurements

H Svedberg, E Chen, H Hamberg-Nyström - Graefe's Archive for Clinical …, 2005 - Springer
Background Excimer laser refractive surgery alters the shape and thickness of the cornea by
removing central corneal tissue with submicrometer precision. The aim of the study was to …

Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34+ progenitor cells

H Svedberg, J Richter, U Gullberg - Leukemia, 2001 - nature.com
The Wilms tumor gene (WT1) encodes a zinc-finger containing transcription factor present
in primitive hematopoietic progenitor cells. WT1 is also highly expressed in most cases of …

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

H Svedberg, K Chylicki, B Baldetorp, FJ Rauscher… - Oncogene, 1998 - nature.com
The Wilms tumor gene, WT1, encodes a zinc-finger DNA binding protein which is thought to
function as a tissue specific transcription factor, regulating cell growth and differentiation. …

p53-mediated differentiation of the erythroleukemia cell line K562

K Chylicki, M Ehinger, H Svedberg, G Bergh, I Olsson… - 2000 - AACR
The tumor suppressor gene p53 can mediate both apoptosis and cell cycle arrest. In addition,
p53 also influences differentiation. To further characterize the differentiation inducing …

Characterization of the molecular mechanisms for p53-mediated differentiation

K Chylicki, M Ehinger, H Svedberg, U Gullberg - 2000 - AACR
The p53 tumor suppressor protein can induce both apoptosis and cell cycle arrest. Moreover,
we and others have shown previously that p53 is a potent mediator of differentiation. For …

[HTML][HTML] Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562

H Svedberg, K Chylicki, U Gullberg - Experimental hematology, 1999 - Elsevier
The Wilms’ tumor gene (WT1) encodes a transcription factor of the zinc finger type. A high
expression of WT1 has been detected in a range of acute leukemias, and WT1 is …